Systemic lupus erythematosus and pregnancy

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 4, 1998, Pages 355-360

  Reichlin, Morris ^a,b,c  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b Arthritis/Immunology Program

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Antiphospholipid antibodies; Lupus erythematosus, systemic; Pregnancy complications

Indexed keywords

BETA2 GLYCOPROTEIN 1; DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOLIPID ANTIBODY; RIBOSOME PROTEIN;

ABORTION; ARTICLE; COMPLETE HEART BLOCK; DISEASE ACTIVITY; HUMAN; OBSTRUCTIVE JAUNDICE; PREGNANCY; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ABORTION, SPONTANEOUS; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; RISK FACTORS;

EID: 0031969367     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Petri M, Howard D, Repke J: Frequency of lupus flare in pregnancy: The Hopkins lupus pregnancy experience. Arthritis Rheum 1991;34:1538-1545
2. Branch DW, Silver RM, Blackwell JL, et al: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80: 614-620
3. Jones DC, Hayslett JP: Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996;335:226-232
4. Martinez-Rueda JO, Arce-Salinas CA, Kraus A, et al: Factors associated with fetal losses in severe systemic lupus erythematosus. Lupus 1996;5:113-119
5. Buyon JP, Cronstein BN, Morris M, et al: Serum complement values (C3 and C4) to differentiate between systemic lupus activity and preeclampsia. Am J Med 1986;81:194-200
6. Buyon JP, Tamerius J, Ordorica S, et al: Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum 1992;35:55-61
7. Lockshin MD: Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989;32:665-670
8. Lockshin MD: Does lupus flare during pregnancy? Lupus 1993;2:1-2
9. Huong DLT, Wechsler B, Piette JC, et al: Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 1994;87: 721-729
10. Buchanan NMM, Khamashta MA, Morton KE, et al: A study of 100 high-risk lupus pregnancies. Am J Reprod Immunol 1992;28:192-194
11. Ruiz-Irastorza G, Lima F, Alves J, et al: Increased rate of lupus flare during pregnancy and the puerperium: Prospective study of 78 pregnancies. Br J Rheumatol 1996;35:133-138
12. Urowitz MB, Gladman DD, Farewell VT, et al: Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-1397
13. Imbasciati E, Surian M, Bottino S, et al: Lupus nephropathy and pregnancy. Nephron 1984;36:46-51
14. Hayslett JP, Lynn RI: Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980;18:207-220
15. Parke A, West B: Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 1996;23: 1715-1718
16. Burmas BL, Hill JA: Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995;38:1722-1732
17. Hulsey M, Goldstein R, Scully L, et al: Antiribosomal P antibodies in systemic lupus erythematosus: A case control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995;74:252-256
18. Martin A, Reichlin M: Fluctuation of antibody to ribosomal "P" proteins correlated with appearance and disappearance of nephritis in SLE. Lupus 1996;5:22-29
19. Lockshin MD, Druzin ML, Qamar T: Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodies. Am J Obstet Gynecol 1989;160:439-443
20. Lynch A, Marlar R, Murphy J, et al: Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994;120:470-476
21. McNeil HP, Simpson RJ, Chesterman CN, et al: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation:beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4124
22. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547
23. Roubey RAS, Pratt C, Buyon JP, et al: Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I. J Clin Invest 1992;90: 1100-1104
24. Lee NS, Brewer HB, Osborne JCJ. Beta2-glycoprotein I: Molecular properties of an unusual apolipoprotein, apolipoprotein. J Biol Chem 1983;258:4765-4770
25. Schousboe I: Beta2-glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985;66:1086-1091
26. Nimpf J, Bevers EM, Bomans PH, et al: Prothrombinase activity of human platelet is inhibited by beta 2 glycoprotein I. Biochem Biophys Acta 1986;884:142-149
27. Nimpf J, Wurm H, Kostner GM: Beta2-glycoprotein I (apo-H) inhibits the release reaction of human platelet during ADP-induced aggregation. Atherosclerosis 1987;63:109-114
28. Cowchock FS, Reece EA, Balaban D, et al: Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166: 1318-1323
29. Branch DW, Silver RM, Blackwell JL, et al: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80: 614-620
30. Schoenlebe J, Buyon JP, Zitelli BH, et al: Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child 1993;147:1072-1075
31. Reichlin M: Antibodies to ribonuclear proteins. Rheum Dis Clin North Am 1994;20:29-43
32. Kephart P, Hood A, Provost TT: Neonatal lupus: Serologic findings. J Invest Dermatol 1981;77:331-333
33. Miyogaura S, Kitamura JW, Yoshioka J, et al: Placental transfer of anticytoplasmic antibodies in annular erythema of newborns. Arch Dermatol 1982;117:569-572
34. Provost TT: Neonatal lupus. Arch Dermatol 1983;119: 619-622
35. Lee LA, Weston WH, Krueger GG, et al: An animal model of antibody binding in cutaneous lupus. Arthritis Rheum 1986; 29:782-788
36. Lee LA, Gaither KK, Coulter SN, et al: Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti Ro/SSA into human skin grafted mice. J Clin Invest 1989; 83:1556-1562
37. Lockshin MD, Bonfa E, Elkon K, et al: Neonatal lupus risks to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum 1989;31:697-701
38. Scott JS, Maddison PJ, Taylor PV, et al: Connective tissue disease, antibodies to ribonucleoprotein and complete congenital heart block. N Engl J Med 1983;309:209-212
39. Litsey SE, Noonan JA, O'Connor WN, et al: Maternal connective tissue disease and congenital heart block: Demonstration of immunoglobulin in cardiac tissue. N Engl J Med 1985;312:98-100
40. Harley JB, Kaine JL, Fox OF, et al: Ro/SSA antibody and antigen in congenital complete heart block. Arthritis Rheum 1985;28:1321-1325
41. Deng JS, Bair JW, Shen-Schwarz S, et al: Localization of the Ro(SS-A) antigen in the cardiac conduction system. Arthritis Rheum 1987;30:1232-1238
42. Buyon JP, Ben-Chetrit E, Kamp SW, et al: Acquired congenital heart block pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro SSB/La systems in neonatal lupus. J Clin Invest 1989;84:627-634
43. Itoh Y, Reichlin M: Autoantibodies to the Ro/SSA antigen are conformation dependent: I. anti 60 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992;14:57-65
44. Reichlin M, Brucato A, Frank MB, et al: Concentration of autoantibodies to native 60 kD Ro/SSA and denatured 52 kD Ro/SSA in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994;37: 1698-1703
45. Lee LA, Pickrell MB, Reichlin M: Development of complete heart block in an adult patient with Sjogren's syndrome and anti Ro/SSA autoantibodies. Arthritis Rheum 1996;39: 1427-1429
46. Callen JP, Fowler JF, Kulick KB, et al: Neonatal lupus erythematosus occurring in one fraternal twin. Arthritis Rheum 1985;28:271-275
47. Cooley HM, Keech CL, Melny JB, et al: Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum 1997;40:381-384
48. Buyon J: Autoantibodies native with Ro(SSA) and La(SSB) and pregnancy. J Rheumatol suppl 50 1997;24:12-16
49. Taylor-Albert E, Reichlin M, Toews WH, et al: Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: Case reports, autoantibody analysis, and management. Pediatrics 1997;99:733-735